U.S. crude oil stocks excluding the Strategic Petroleum Reserve (SPR) fell last week to their lowest since April 2022 as ...

Mizuho analyst Nitin Kumar lowered the firm’s price target on CNX Resources (CNX) to $34 from $38 and keeps an Underperform ...

Mizuho raised the firm’s price target on Vital Energy (VTLE) to $38 from $37 and keeps a Neutral rating on the shares. The firm expects a modest beat for Q4, driven by modestly higher oil volumes and ...

Japan’s yen strengthened on Wednesday (Jan 15) on growing bets on a rate hike at the Bank of Japan’s next meeting, while ...

Japan's yen strengthened on Wednesday on growing bets on a rate hike at the Bank of Japan's next meeting, while cooling ...

In a report released today, Dan Dolev from Mizuho Securities reiterated a Buy rating on Accenture (ACN – Research Report), with a price target ...

In a report released on January 13, David Bellinger from Mizuho Securities maintained a Hold rating on Five Below (FIVE – Research Report). The ...

Jared Holz, Mizuho, joins 'Fast Money' to talk how to play Eli Lilly's stock right now.

ADB says around $38.8 million of the finance package for the geothermal project will come from the bank’s ordinary capital ...

With an average consensus target price 33% higher than its current $190 stock price, Onto Innovation is deemed a compelling ...

Advanced Micro Devices (NASDAQ:AMD – Free Report) had its price objective lowered by Wells Fargo & Company from $205.00 to $165.00 in a research report report published on Monday,Benzinga reports.

Less than two months after scoring what analysts deemed a "best-case" FDA approval for its cardiomyopathy drug Attruby, ...